Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 172,826 | 155,753 | 159,490 | 136,786 | 135,702 |
| Cost of Goods | 63,938 | 56,714 | 52,228 | 43,767 | 42,681 |
| Gross Profit | 108,888 | 99,039 | 107,262 | 93,019 | 93,021 |
| Operating Expenses | 80,907 | 122,392 | 71,079 | 78,699 | 74,110 |
| Operating Income | 28,919 | -22,639 | 36,411 | 15,087 | 19,592 |
| Interest Expense | 3,704 | 3,674 | 3,616 | 3,605 | 784 |
| Other Income | 4,673 | 3,948 | 3,927 | 3,954 | 3,197 |
| Pre-tax Income | 29,888 | -22,365 | 36,722 | 15,436 | 22,005 |
| Income Tax | 11,854 | -10,759 | 16,141 | 6,172 | 8,251 |
| Net Income Continuous | 18,034 | -11,606 | 20,581 | 9,264 | 13,754 |
| Minority Interests | -60 | -33 | -82 | -1 | -1 |
| Net Income | $18,094 | $-11,573 | $20,663 | $9,265 | $13,755 |
| EPS Basic Total Ops | 0.33 | -0.21 | 0.39 | 0.18 | 0.25 |
| EPS Basic Continuous Ops | 0.32 | -0.21 | 0.39 | 0.18 | 0.25 |
| EPS Diluted Total Ops | 0.30 | -0.21 | 0.37 | 0.17 | 0.25 |
| EPS Diluted Continuous Ops | 0.30 | -0.21 | 0.37 | 0.17 | 0.25 |
| EBITDA(a) | $38,836 | $-14,051 | $41,171 | $19,693 | $22,347 |